$20.83
-0.140 (-0.668%)
At Close: Jun 03, 2026
MEXC SPACEX(PRE) Phase 2 Launchpad: 30% Off Subscription and Extra Airdrops for Stock Trading
06:00am, Monday, 01'st Jun 2026
SpaceX Launchpad's total subscription allocation has expanded to 7 million USDT, equivalent to 53,800 SPACE(PRE). The subscription price is set at 130 USDT
BNP PARIBAS PRESENTS THE GROWTH STRATEGY OF ITS COMMERCIAL BANK IN BELGIUM (CPBB) AND RAISES ITS PROFITABILITY TARGETS TO 22% PRE-TAX RONE IN 2028 AND 25% IN 2030
MEXC SPACEX(PRE) Launchpad Subscriptions Surpass $56 million, with the Offering Oversubscribed by Up to 15.5x
06:00am, Friday, 22'nd May 2026
MEXC SPACEX(PRE) Launchpad is with total subscriptions surpassing $56 million and the most competitive pool reaching an oversubscription rate of 15.5x.
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
08:00am, Wednesday, 20'th May 2026
Multi-year partnership lands as Prenetics' IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026 Shetty is IM8's first global
Prenetics Global Q1 Earnings Call Highlights
03:07pm, Thursday, 14'th May 2026
Prenetics Global NASDAQ: PRE said its first-quarter results reflected the company's shift away from diagnostics and genome testing toward a subscription-driven consumer health model anchored by its IM
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
08:05am, Thursday, 14'th May 2026
~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion
Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million , up 23.1% from IM8 revenue of $27.4 million in Q4 2025 Raises full-year 2026 IM8 revenue guidance to $190 millio
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
08:30am, Friday, 08'th May 2026
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with Davi
Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
08:30am, Thursday, 07'th May 2026
NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co
TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, April 29, 2026 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased
Prenetics Global: Quarterly Subscription Focus Could Turn $120M AAR Into A Billion-Dollar Machine
07:23am, Friday, 24'th Apr 2026
I am strongly bullish on Prenetics Global Limited, driven by the IM8 product and a successful shift to quarterly subscriptions doubling customer value. PRE's revenue is projected to grow 105.7% YoY in
Prenetics Global: On Course To Hit Profitability Amid Globalization Drive
11:08am, Saturday, 18'th Apr 2026
Prenetics Global Limited (PRE) remains a buy, with a 15% near-term and 60% 24-month upside potential based on robust revenue growth projections. PRE's strategic focus on IM8, divestiture of non-core a
Comparing Prenetics Global (NASDAQ:PRE) & GH Research (NASDAQ:GHRS)
04:27am, Wednesday, 15'th Apr 2026
Prenetics Global (NASDAQ: PRE - Get Free Report) and GH Research (NASDAQ: GHRS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two busi
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
11:00am, Tuesday, 24'th Mar 2026
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and
Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at Conference
02:03am, Monday, 23'rd Mar 2026
Prenetics Global (NASDAQ: PRE) CEO and co-founder Danny Yeung told investors the company delivered what he described as a "breakout growth story" in 2025, driven by the rapid expansion of its IM8 dire
Sign In
Buy PRE